EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Symptom Network Analysis in Patients With Primary Sclerosing Cholangitis

Melinda Wang iD, Amy M Shui iD, Joanne Hatchett iD, Stephen J Rossi iD, Ruth-Anne Pai, Rachel Gomel iD, Mary Pressley Vyas iD, Sarah Curup Callif iD, Ricky Safer, Jessica Rubin iD, Christopher Bowlus iD, Donna M Evon iD und 2 weitere

Canadian Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1155/cjgh/5291248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, 2026. Verfasst von Melinda Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of California, San Francisco, California, USA, berkeley.edu. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Quality of Life. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PSC Partners Young Investigator Award, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with primary sclerosing cholangitis (PSC) experience numerous symptoms that impact quality of life. We sought to identify PSC‐specific symptom clusters and relationships between symptoms to better understand the lived experience of PSC patients.

Methods

Presence and severity of 16 symptoms were identified from the international “Our Voices” survey collected by PSC Partners Seeking A Cure in 2020. LASSO‐regularized partial correlation network analysis was performed using Spearman correlations. The primary analysis utilized symptoms reported within the past 6 months of survey completion, with subgroup analyses conducted on patients with and without inflammatory bowel disease (IBD). Expected influence was computed to quantify the importance of each measure within networks. The Spinglass algorithm was employed to identify communities within networks.

Results

Among 970 total participants, 54% were women, and 70% had IBD. Four dominant communities were identified across networks, including global symptoms, psychological symptoms, gastrointestinal symptoms, and cholestatic‐related symptoms. Of the 16 symptoms included in network analyses, fatigue and weakness had the most positive influence across multiple networks and across different communities within each network.

Conclusions

The complex relationship between co‐occurring symptoms in PSC organizes into four dominant symptom clusters. FTG and WEA emerged as strongly influential symptoms that consistently were associated with other symptoms. Our analyses emphasize the complex, co‐occurring nature of PSC symptoms, identify highly influential symptoms, and highlight the need to develop patient‐reported outcome symptom measures to assess changes in these key symptoms in clinical trials and clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingQuality of LifeHumansFemaleMaleAdultMiddle AgedSymptom BurdenInflammatory Bowel DiseasesSeverity of Illness IndexFatigueSurveys and Questionnaires

Stichwörter der Autor:innen

clusterfatiguenodesurveyweakness

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, University of California, San Francisco, California, USA, berkeley.edu.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA, berkeley.edu.
  • PSC Partners Seeking a Cure, Greenwood Village, Colorado, USA.
  • PSC Partners Seeking a Cure Canada, Toronto, Ontario, Canada.
  • University of California Davis Health, Sacramento, California, USA, ucdavis.edu.
  • Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA, unc.edu.

ORCID-Profile: Melinda Wang, Amy M Shui, Joanne Hatchett, Stephen J Rossi, Rachel Gomel, Mary Pressley Vyas, Sarah Curup Callif, Jessica Rubin, Christopher Bowlus, Donna M Evon, Jennifer C Lai

Förderung

  • PSC Partners Young Investigator Award
  • NIDDK NIH HHS
  • NIH HHS
  • Liver Center, University of California, San Francisco
  • National Institutes of Health

Zitieren

APA

Wang, M., Shui, A. M., Hatchett, J., Rossi, S. J., Pai, R. A., Gomel, R., Vyas, M. P., Callif, S. C., Safer, R., Rubin, J., Bowlus, C., Evon, D. M., Lai, J. C., & Li, M. (2026). Symptom Network Analysis in Patients With Primary Sclerosing Cholangitis. Canadian Journal of Gastroenterology and Hepatology. https://doi.org/10.1155/cjgh/5291248

Vancouver

Wang M, Shui AM, Hatchett J, Rossi SJ, Pai RA, Gomel R, et al. Symptom Network Analysis in Patients With Primary Sclerosing Cholangitis. Canadian Journal of Gastroenterology and Hepatology. 2026. doi:10.1155/cjgh/5291248

BibTeX
@article{Wang2026,
  author = {Wang, Melinda and Shui, Amy M and Hatchett, Joanne and Rossi, Stephen J and Pai, Ruth-Anne and Gomel, Rachel and Vyas, Mary Pressley and Callif, Sarah Curup and Safer, Ricky and Rubin, Jessica and Bowlus, Christopher and Evon, Donna M and Lai, Jennifer C and Li, Michael},
  title = {Symptom Network Analysis in Patients With Primary Sclerosing Cholangitis},
  journal = {Canadian Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1155/cjgh/5291248}
}
Kostenlos starten →